Charlotte Aubin: A New Perspective on BDNF’s Influence on Hemostasis and Thrombotic Risk
Charlotte Aubin, Research Student at Montreal Heart Institute, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Current Opinion in Hematology, adding:
“I am thrilled to share that my first scientific publication has now been published in Current Opinion in Hematology!
‘The Dual Role of the Brain-Derived Neurotrophic Factor as a Regulator of Hemostasis and Thrombotic Risk.’
As first co-author, I had the opportunity to contribute to this invited review exploring the role of brain-derived neurotrophic factor (BDNF) and its receptors in platelet biology, hemostasis, thrombosis, and cardiovascular disease, alongside Jessica Blais and Yanitsa Petkova.
A huge thank you to my supervisor, Marie Lordkipanidze, and the entire team in our lab at the Santé Québec – Institut de cardiologie de Montréal for their guidance, support, and encouragement throughout this process!”
Title: The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk
Authors: Charlotte Aubin, Jessica Blais, Yanitsa Petkova, Marie Lordkipanidzé

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian